Cargando…
Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trial
BACKGROUND: The purpose of the present study was to determine the effect of additional calcium carbonate treatment on fibroblast growth factor 23 (FGF23) levels in patients treated with calcitriol. METHODS: In this randomized, open-labeled, and parallel-group study, a total of 30 patients with early...
Autores principales: | Han, Nayoung, Hong, Su Hyun, Kim, Yon Su, Kim, Dong Ki, Kim, In-Wha, Ji, Eunhee, Oh, Jung Mi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565373/ https://www.ncbi.nlm.nih.gov/pubmed/28860784 http://dx.doi.org/10.2147/TCRM.S142564 |
Ejemplares similares
-
Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol
por: Cheng, Qun, et al.
Publicado: (2018) -
Neurochemical Effects of Chronic Administration of Calcitriol in Rats
por: Jiang, Pei, et al.
Publicado: (2014) -
Calcium–Calcitriol: A Match made in Heaven?
por: Balachandran, Karthik, et al.
Publicado: (2019) -
Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han, Nayoung, et al.
Publicado: (2021) -
Effect of Prophylactic Calcitriol Administration on Serum Ionized Calcium Concentrations after Parathyroidectomy: 78 Cases (2005–2015)
por: Armstrong, A.J., et al.
Publicado: (2017)